Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 3/2007

01.06.2007

Acute Tumor Lysis Syndrome Caused by Transcatheter Oily Chemoembolization in a Patient with a Large Hepatocellular Carcinoma

verfasst von: Noriaki Sakamoto, Shuichi Monzawa, Hidenobu Nagano, Hogara Nishizaki, Yasuaki Arai, Kazuro Sugimura

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

Acute tumor lysis syndrome results from a sudden and rapid release of products of cellular breakdown after anticancer therapy. Severe alterations of metabolic profile might occur and result in acute renal failure. We present a patient with a large hepatocellular carcinoma who received transcatheter oily chemoembolization and died subsequently of this syndrome. To our knowledge, there has been only one report of this syndrome induced by chemoembolization for hepatocellular carcinoma. This case illustrates the need to anticipate the development of acute tumor lysis syndrome when chemoembolization is planned for a large hepatocellular carcinoma.
Literatur
1.
2.
3.
Zurück zum Zitat Chasty RC, Liu-Yin JA (1993) Acute tumour lysis syndrome. Br J Hosp Med 49(7):488–492PubMed Chasty RC, Liu-Yin JA (1993) Acute tumour lysis syndrome. Br J Hosp Med 49(7):488–492PubMed
4.
Zurück zum Zitat Burney IA (1998) Acute tumor lysis syndrome after transcatheter chemoembolization of hepatocellular carcinoma. South Med J 91(5):467–470PubMed Burney IA (1998) Acute tumor lysis syndrome after transcatheter chemoembolization of hepatocellular carcinoma. South Med J 91(5):467–470PubMed
5.
Zurück zum Zitat Child CG, Turcotte JG (1964) Surgery and portal hypertension. In: Child CG, ed. The Liver and Portal Hypertension. Philadelphia: Saunders, pp 1–85 Child CG, Turcotte JG (1964) Surgery and portal hypertension. In: Child CG, ed. The Liver and Portal Hypertension. Philadelphia: Saunders, pp 1–85
6.
Zurück zum Zitat Malinchoc M, Kamath PS, Gordon FD, et al. (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31(4):864–871PubMedCrossRef Malinchoc M, Kamath PS, Gordon FD, et al. (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31(4):864–871PubMedCrossRef
7.
Zurück zum Zitat Chung JW, Park JH, Im JG, et al. (1993) Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 187(3):689–693PubMed Chung JW, Park JH, Im JG, et al. (1993) Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 187(3):689–693PubMed
8.
Zurück zum Zitat Drakos P, Bar-Ziv J, Catane R (1994) Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature. Am J Clin Oncol 17(6):502–505PubMedCrossRef Drakos P, Bar-Ziv J, Catane R (1994) Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature. Am J Clin Oncol 17(6):502–505PubMedCrossRef
9.
10.
Zurück zum Zitat Vogelzang NJ, Nelimark RA, Nath KA (1983) Tumor lysis syndrome after induction chemotherapy of small-cell bronchogenic carcinoma. JAMA 249(4):513–514PubMedCrossRef Vogelzang NJ, Nelimark RA, Nath KA (1983) Tumor lysis syndrome after induction chemotherapy of small-cell bronchogenic carcinoma. JAMA 249(4):513–514PubMedCrossRef
11.
Zurück zum Zitat Cech P, Block JB, Cone LA, et al. (1986) Tumor lysis syndrome after tamoxifen flare. N Engl J Med 315(4):263–264PubMedCrossRef Cech P, Block JB, Cone LA, et al. (1986) Tumor lysis syndrome after tamoxifen flare. N Engl J Med 315(4):263–264PubMedCrossRef
12.
Zurück zum Zitat Oosterom A (1991) Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma. Cancer 67(8):2207–2210PubMedCrossRef Oosterom A (1991) Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma. Cancer 67(8):2207–2210PubMedCrossRef
13.
Zurück zum Zitat Tomlinson GC, Solberg LA Jr (1984) Acute tumor lysis syndrome with metastatic medulloblastoma. A case report. Cancer 53(8):1783–1785PubMedCrossRef Tomlinson GC, Solberg LA Jr (1984) Acute tumor lysis syndrome with metastatic medulloblastoma. A case report. Cancer 53(8):1783–1785PubMedCrossRef
14.
Zurück zum Zitat Nakamura H, Tanaka T, Hori S, et al. (1983) Transcatheter embolization of hepatocellular carcinoma: Assessment of efficacy in cases of resection following embolization. Radiology 147(2):401–405PubMed Nakamura H, Tanaka T, Hori S, et al. (1983) Transcatheter embolization of hepatocellular carcinoma: Assessment of efficacy in cases of resection following embolization. Radiology 147(2):401–405PubMed
15.
Zurück zum Zitat Bronowicki JP, Vetter D, Dumas F, et al. (1994) Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients. Cancer 74(1):16–24PubMedCrossRef Bronowicki JP, Vetter D, Dumas F, et al. (1994) Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients. Cancer 74(1):16–24PubMedCrossRef
16.
Zurück zum Zitat Nakamura H, Hashimoto T, Oi H, et al. (1989) Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170(3 Pt 1):783–786PubMed Nakamura H, Hashimoto T, Oi H, et al. (1989) Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170(3 Pt 1):783–786PubMed
17.
Zurück zum Zitat de Groupe d’Etude et Traitement du Carcinome Hepatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332(19):1256–1261CrossRef de Groupe d’Etude et Traitement du Carcinome Hepatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332(19):1256–1261CrossRef
18.
Zurück zum Zitat Pelletier G, Roche A, Ink O, et al. (1990) A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 11(2):181–184PubMedCrossRef Pelletier G, Roche A, Ink O, et al. (1990) A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 11(2):181–184PubMedCrossRef
19.
Zurück zum Zitat Chung JW, Park JH, Han JK, et al. (1996) Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 198(1):33–40PubMed Chung JW, Park JH, Han JK, et al. (1996) Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 198(1):33–40PubMed
Metadaten
Titel
Acute Tumor Lysis Syndrome Caused by Transcatheter Oily Chemoembolization in a Patient with a Large Hepatocellular Carcinoma
verfasst von
Noriaki Sakamoto
Shuichi Monzawa
Hidenobu Nagano
Hogara Nishizaki
Yasuaki Arai
Kazuro Sugimura
Publikationsdatum
01.06.2007
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 3/2007
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-005-0240-8

Weitere Artikel der Ausgabe 3/2007

CardioVascular and Interventional Radiology 3/2007 Zur Ausgabe

PET kann infarktgefährdete Koronararterien entdecken

04.06.2024 Koronare Herzerkrankung Nachrichten

Der Nachweis aktiver Plaques mittels 18F-Natriumfluorid-PET hilft nicht nur, infarktgefährdete Patienten, sondern auch infarktgefährdete Koronararterien zu erkennen. Von einer gezielten Behandlung vulnerabler Plaques ist man trotzdem weit entfernt.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.